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ABSTRACT The human immunodeficiency virus type 1
nefgene induces endocytosis of CD4 antigen and disrupts the
association between CD4 and p56Ick protein-tyrosine kinase
(EC 2.7.1.112). We demonstrate that in T cells these effects of
the viral protein require a cluster of hydrophobic amino acids
in a membrane-proximal region of the CD4 cytoplasmic tail;
other amino acids in the C-terminal segment of CD4 cyto-
plasmic tail also contribute to the interaction. Mutations in
CD4 that prevent down-modulation by Nef also decrease CD4
association with p56lck and prevent Nef-induced disruption of
CD4-p56lck complexes. Together, the overlap in CD4 se-
quences required for interaction with Nef and p56lck and the
tight correlation between Nef-induced CD4 down-modulation
and disruption of CD4-p56Ick association suggest that Nef, or
cellular factors recruited by Nef, interact with this segment of
CD4 to displace p56lck from the complex and induce CD4
endocytosis.
nef genes of human and simian immunodeficiency viruses
(HIV, SIV) encode related N-terminally myristoylated cyto-
plasmic proteins (1, 2). nef is essential for high viral load and
pathogenesis in vivo (3) but is not required for viral replication
under commonly used in vitro conditions (3-5). The mecha-
nism by which Nef stimulates viral replication in vivo is
unknown but may involve down-modulation of CD4 antigen
expression on the cell surface, as has been observed with a
large fraction of nef alleles derived from laboratory HIV and
SIV isolates and from peripheral blood leukocytes of HIV-
infected patients (6-11). Nef-induced down-modulation of
CD4 on the cell surface reflects accelerated CD4 endocytosis
and its degradation in the lysosomal compartment (12, 13).
CD4 is a transmembrane glycoprotein expressed at high
levels on helper T cells and is essential for their ontogeny and
antigen-specific responses (14-17). In T cells, the short cyto-
plasmic domain of CD4 is involved in at least two interactions.
One is with the p56lck protein-tyrosine kinase (EC 2.7.1.112)
(18, 19) and this association is required for antigen-specific
signaling (15). The CD4-p56lck association requires cysteine
motifs in the CD4 cytoplasmic tail and the N terminus of p56lck
and may involve direct binding of the two proteins (20,21). The
cysteine motif in CD4 is not sufficient for binding p56lck, as a
deletion of the membrane-proximal segment of the CD4
cytoplasmic tail prevents association of the two proteins (13,
21).
The other interactions involve CD4 endocytosis induced by
Nef and/or phorbol ester [phorbol 12-myristate 13-acetate
(PMA)]. PMA-induced (22) and Nef-induced CD4 endocyto-
sis (12) and CD4 targeting to the lysosomal compartment
require a di-leucine motif in the membrane-proximal region of
CD4 cytoplasmic tail. CD4 endocytosis induced by PMA is
initiated by phosphorylation of serines located in a close
proximity to the di-leucine motif, an event mediated by protein
kinase C (22, 23). In contrast, the effect of Nef on CD4 does
not involve serine phosphorylation, or formation of stable
complexes between the two proteins (7, 12, 13), and the events
involved in Nef interaction with CD4 are not known. Neither
the effect of Nef nor the effect of PMA requires p56lck or the
cysteine motif in CD4 cytoplasmic tail, which is important for
association with ps6lck; yet CD4 endocytosis induced by either
of these agents involves disruption of CD4 association with
p56lck (12, 13, 23-27). Mechanisms mediating this process are
not clear. To address the mechanism of Nef interaction with
CD4-p56lck complexes, we have, studied the sequence require-
ments within the CD4 cytoplasmic tail for down-modulation by
Nef and for interaction with p56lck in T cells.
MATERIALS AND METHODS
Construction of CD4 Mutants and Expression in 171.22 T
Cells. Mutant CD4 cDNAs were constructed by oligonucle-
otide-directed site-specific mutagenesis (8) and subcloned into
the BamHI site of pBABE(neo) retroviral expression vector
(28); the resulting constructs were transfected into the GPE-86
packaging cell line (29). 171.22 cells, a clonal line isolated from
the previously described 171 T-cell hybridoma (ref. 15; S.S. and
J.S., unpublished data), were infected by coculture with pro-
ducer GPE-86 cells. CD4+ 171.22 T cells were isolated by cell
sorting. For analysis of CD4 expression on the cell surface, 2
X 105 cells were incubated with saturating amounts of phyco-
erythrin-conjugated Leu3A monoclonal antibody (mAb) (Bec-
ton Dickinson) and analyzed on the EpicsC flow cytometer as
described (8, 9).
Expression of HIV-1 Nef in CD4+ 171.22 Cells. pBABE-
(puro) vector containing NA13 nef (8) was introduced into
GPE-86 cells and supernatants were used to infect 171.22 cells
expressing various forms of CD4 proteins. Transduced cells
were selected for 4 days with puromycin (0.8 ,ug/ml).
Immunoprecipitation and Immunoblot Analysis. Cytoplas-
mic lysates from a total of 2 x 107 to 4 x 107 cells were
prepared and immunoblot analysis of Nef expression was
performed as described (9). For immunoprecipitation, ali-
quots of extracts were precleared for 1 hr with 30 Al of protein
G-agarose beads (GIBCO) and then incubated for 4 hr with 10
,ul of protein G beads that had been allowed to react with 4 jig
of OKT4 mAb (Ortho Diagnostics). Immune complexes were
washed as described (9). For immunoblotting, immune com-
plexes were denatured for 15 min at 70°C in nonreducing
sample buffer, resolved on 12% polyacrylamide gels, and
transferred to poly(vinylidene difluoride) membrane (9). Im-
munoblot analysis with rabbit serum reacting with p56lck
(Santa Cruz Biotechnology, Santa Cruz, CA) or with human
CD4 (Cambridge Biotech) was performed as described (9) and
developed using the ECL detection system (Amersham).
Abbreviations: HIV-1, human immunodeficiency virus type 1; PMA,
phorbol 12-myristate 13-acetate; mAb, monoclonal antibody.
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RESULTS
In T Cells Nef-Induced CD4 Endocytosis Involves a Cluster
of Hydrophobic Amino Acid Residues in the CD4 Cytoplasmic
Tail. To examine the CD4 sequences required for down-
modulation by Nef, CD4 proteins bearing various mutations in
the cytoplasmic tail were expressed in the CD4- 171.22 T-cell
hybridoma. The derived cell lines were subsequently trans-
duced with a retroviral vector containing either an active allele
of HIV-1 nef (NA13) (8) or an empty control vector. Expres-
sion ofCD4 on the cell surface of the resultant populations was
then analyzed by flow cytometry (Fig. 1A). Representative
results from such an experiment are shown in Fig. 1B. Ex-
pression of the strong (NA13) HIV-1 nef allele in the context
of wild-type CD4 resulted in complete loss of CD4 antigen
from the surface of 171.22 cells (compare panels 1A and 1B in
Fig. 1B). In agreement with previous observations (12, 13),
deletion of the last 15 amino acids from the cytoplasmic tail of
CD4 (d418), including residues C420 and C422, which are
essential for CD4-p56lck association, had no detectable effect
on CD4 down-modulation. However, more extensive trunca-
tions past residue K418, or deletions eliminating residues
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M407 to R412 or R412 to K417, severely attenuated the
Nef-induced CD4 down-modulation (Fig. 1A, mutants d415,
d409, d402, or d407-412, d412-417, respectively). This indi-
cated a critical role for one or more residues located between
positions M407 and K412, in addition to leucine 413/414.
Notably, the residual responsiveness of the latter two mutants
was eliminated by combining them with a deletion of the last
10 C-terminal amino acids of the CD4 cytoplasmic tail (see
d407-412/d423 and d412-417/d423, Fig. 1A). Thus, although
the region distal to residue C422 is not essential for down-
modulation by Nef in the context of wild-type CD4, it does
contribute in the context of partially unresponsive CD4 pro-
teins.
To assess which amino acids in the CD4 cytoplasmic tail are
required for down-modulation by Nef, mutants bearing double
or triple amino acid substitutions in this region were analyzed.
As shown in Fig. 1A, substitutions at positions proximal to
M407 and distal to K418 had no detectable effect on Nef-
induced CD4 down-modulation (Q403A, E405G, R406A;
T419A, Q421A; C420A, C422A). In contrast, two sets of
substitutions in the region between M407 and S416 resulted in
CD4 proteins that were unresponsive to Nef. Replacement of
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FIG. 1. Analysis of HIV-1 Nef-induced down-modulation of CD4 in 171.22 T cells. (A) Effect of mutations in CD4 cytoplasmic domain on
down-modulation by Nef and on association with pS61ck. Amino acid sequences of the cytoplasmic tails of mutant CD4 proteins are aligned on the
left with that of the wild-type human CD4. Dots (.) indicate amino acid identities with the wild-type protein, dashes (-) indicate the extent of internal
deletions, and letters identify amino acid substitutions in the single-letter code. The 12-amino acid membrane-proximal region in CD4 cytoplasmic
tail required for down-modulation by Nef is boxed. Mutant CD4 proteins were expressedc in 171.22 cells and analyzed as described in the text.
Following staining with Leu3A anti-CD4 mAb, fluorescence of cells expressing various CD4 proteins was 50-60channels (on the 256-channel
logarithmic scale) higher than that of the parental CD4- 171.22 cells. The extent of change in CD4 expressiolTowing transduction with HIV-1
NA13 nef expression vector (Nef) is indicated by + + +, + +, +, +/- and -, which reflect a decrease in the fluorescence intensity of 35-55, 20-35,
10-20, 5-10, and <5 channels, respectively. Quantitation of CD4-p561ck association was performed by Western blot analysis, as shown in the Fig.
2, and is based on two independent experiments. The degree of p56lck association with mutant CD4 proteins was normalized to that observed with
wild-type CD4 (1.0). ND, not determined. (B) Down-modulation of selected mutant CD4 proteins by HIV-1 NA13 Nef in 171.22 T cells, 171.22
cells expressing human CD4 (panel 1) or selected CD4 mutants (panels 2-6) and transduced with a control empty vector (row A) or with HIV-1
nef (row B) were stained with phycoerythrin-Leu3A anti-CD4 antibody and analyzed on an EPICS C flow cytometer (row A). The abscissa gives
the fluorescence intensity in a logarithmic scale. The ordinate gives a relative cell number. (C) Immunoblot analysis of Nef expression. Detergent
extracts prepared from cells expressing wild-type CD4 or mutant proteins and transduced with HIV-1 nef expression vector were analyzed by
immunoblotting with HIV-1 nefantiserum (lanes 2-7). Extracts prepared from the parental cells expressing CD4 onlywere used as a negative control
(lanes 1 and 8). Asterisks (*) indicate cross-reacting background bands.
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leucines 413 and 414 by alanines abrogated down-modulation
by Nef (L413A, L414A, panels 5A and 5B in Fig. 1B), while
the double alanine substitution for methionine 407 and iso-
leucine 410 (M407A, 1410A) still responded to Nef, but at
much reduced levels (panels 2A and 2B in Fig. 1B). Deleting
10 amino acids from the C-terminal end of the latter mutant
CD4 resulted in unresponsiveness to Nef (M407A, 1410A/
d423, panels 3A and 3B in Fig. 1B). Together these data
demonstrate that CD4 down-modulation by Nef requires a
cluster of hydrophobic amino acids in the membrane-proximal
region of CD4 cytoplasmic tail and provide further evidence
that the C-terminal region of the tail contributes to the
interaction of CD4 with Nef. Immunoblot analysis demon-
strated steady-state levels of Nef protein in mutant CD4 cell
lines (M407A, 1410A; M407A, 1410A/d423; and L413A,
L414A) at levels greater than, or equal to, that in the wild-type
CD4 cell line (Fig. lC).
Efficient CD4-p56Ick Association Requires the Nef-
Responsive Element. In T cells, the cytoplasmic tail of CD4 is
associated with p56lck protein-tyrosine kinase (18, 19). As the
hydrophobic element required for Nef-induced CD4 endocy-
tosis and the double cysteine motif (C420, C422) involved in
CD4 association with p56lck (20, 21) are located in close
proximity in the CD4 cytoplasmic tail, we tested whether the
region that is involved with CD4 endocytosis also interacts
with pS6lck.
Association of mutant CD4 proteins with endogeneous
p56Ick was analyzed by immunoblot analysis of anti-CD4
immune complexes prepared from detergent lysates of 171.22
cells expressing selected CD4 proteins. Immunoblotting with
CD4-specific serum revealed that similar amounts of the
wild-type and mutant CD4 proteins were expressed in these
cells (compare lanes 8-19 with lanes 2-6, Fig. 2, lower panel).
Several of the mutations affecting residues M407 through
K418, the region required for CD4 endocytosis, resulted in a
decrease in CD4-associated p56lck (see upper panel in Fig. 2
and compilation in Fig. 1A). A large deletion spanning resi-
dues Q403 through K418 resulted in a >20-fold reduction of
CD4-p56lck association (d403-418, compare lanes 8 and 10,
Fig. 2) as did a smaller deletion spanning residues R412
through K417 (d412-417, lane 13). In contrast, deletion of
residues M407 through R412 had a less dramatic effect,
resulting in an -4- to -8-fold decrease in coimmunoprecipi-
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FIG. 2. Effect of mutations in CD4 cytoplasmic tail on association
with pS6lck. Lysates were prepared from 2 x 107 cells expressing
wild-type human CD4 (CD4) or selected mutant CD4 proteins and
were immunoprecipitated with OKT4 anti-CD4 mAb. Western blots of
immune complexes were probed with antiserum specific for p561ck
(a-lck, upper panel) or human CD4 (a-CD4, lower panel). Two-fold
serial dilutions of protein extracts prepared from COS7 cells tran-
siently transfected with pS61ck, or human CD4, expression vectors were
used as standards for quantitation (lanes 1-6 in the upper and lower
panels, respectively). Aliquots of an extract prepared from untrans-
fected COS7 cells were used as a negative control (m, lanes 7).
tated p561ck (d407-412, compare lanes 8 and 12), whereas
deletion of more membrane-proximal residues Q403 through
R406 had little, if any, effect on CD4-p561ck association
(d403-406, lane 11). Interestingly, deletion of the C-terminal
10 amino acids in the cytoplasmic tail also showed a 2- to 4-fold
decrease in CD4-associated p56lck (d423, compare lanes 9 and
8). Thus, the results of deletional analysis indicate that CD4
sequences required for down-modulation by Nef also contrib-
ute to interaction with p561ck.
This is more clearly seen with analysis of alanine substitution
mutants. For example, substitution of alanines for M407 and
1410, which dramatically reduces CD4 down-modulation by
Nef, resulted in an -2- to -4-fold reduction in CD4-associated
p561ck (M407A, I410A, compare lanes 14 and 15, Fig. 2, upper
panel). When the same mutations were combined with dele-
tion d423 (which lacks 10 C-terminal amino acids but retains
residues C420 and C422 and is completely unresponsive to
Nef), no detectable p561ck was coimmunoprecipitated
(M407A, I410A/d423, lane 16). Moreover, when alanines were
substituted for L413 and L414, which abolishes CD4 internal-
ization induced by Nef, the amount of coimmunoprecipitated
p561ck was only one-eighth to one-fourth of that observed with
wild-type CD4 (L413A, L414A, compare lanes 14 and 19). In
contrast, substitutions at K411 and R412, which had no effect
on Nef-induced CD4 endocytosis (Fig. 1A), resulted in only a
modest decrease in association with p56Ick (compare lanes 17
and 18 with lane 19). These results indicate that the hydro-
phobic amino acid residues in the membrane-proximal region
in the CD4 cytoplasmic tail that are required for down-
modulation by Nef are also involved with efficient recruitment
of p56lck into a complex with CD4 and/or with stabilization of
the complex.
Different Sequence Requirements for Disruption of CD4-
p56Ick Association by Nef and PMA. PMA-induced CD4
endocytosis involves dissociation of CD4-p561ck complexes
prior to internalization of the CD4 molecule (25-27). To assess
the relationship between Nef-induced disruption of CD4-
p56lck association and CD4 internalization, we asked whether
these two functions can be separated genetically by mutations
in the CD4 cytoplasmic tail.
As shown in Fig. 3A, coexpression of wild-type CD4 and
NA13 Nef resulted in an -2- to -3-fold lower steady-state
level of CD4 (compare lanes 1 and 3, lower panel). This
decrease is consistent with an accelerated CD4 turnover and
lysosomal degradation induced by Nef proteins (12, 13). The
residual CD4 detected in cells expressing Nef reflects the
intracellular pool, as no detectable staining of these cells with
anti-CD4 antibody was observed by flow cytometry analysis
(see Fig. 1B, panels 1A and 1B). Similar reduction of the
steady-state CD4 was also detected following PMA treatment,
and the effects of Nef and PMA were not additive (lanes 2 and
4). In contrast, immunoblot analysis with p56lck antiserum
revealed an -20-fold decrease in CD4-associated p561ck in
Nef-expressing or PMA-treated cells (compare lanes 2, 3, and
1, upper panel), indicating that the majority of the intracellular
pool of CD4 was not complexed with p561ck. The higher
molecular forms of p56lck observed with PMA-treated cells,
but not Nef-expressing cells, may reflect its serine phosphor-
ylation known to be associated with activation of protein
kinase C (see lanes 2 and 3 in upper panel; refs. 27 and 30).
Fig. 3 B and C show that two sets of amino acid substitutions
that compromise Nef-induced CD4 down-modulation and
reduce CD4-p561ck association also prevented disruption of
CD4-p56lck association by Nef. Alanine substitutions at resi-
dues M407 and 1410 (M407A, I410A), which compromise CD4
internalization induced by Nef (see Fig. 1B, panels 2A and 2B),
prevented a decrease in the steady-state level of CD4 (M407A,
I410A, compare lanes 1 and 3, Fig. 3B, lower panel). Surpris-
ingly, this mutation resulted in a 2- to 3-fold increase in the
amount of associated p56lck in the presence of Nef (M407A,
Cell Biology: Salghetti et at
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FIG. 3. Effect of HIV-1 Nef or PMA on the association of p56lck with mutant CD4 proteins in 171.22 T cells. (A) Lysates were prepared from
parental cells expressing human CD4 (lanes 1 and 2) and from a derivative population transduced with HIV-1 nef (lanes 3 and 4), which were
cultured for 1 hr in the presence (lanes 2 and 4) or absence (lanes 1 and 3), of PMA (50 ng/ml). A similar analysis was performed with M407A,
1410A (B), L413A, L414A (C), and K411D, R412E (D) CD4 mutants. Immune complexes were isolated and analyzed as described in the legend
to Fig. 2.
I410A, compare lanes 1 and 3, Fig. 3B, upper panel). This
increase may result from altered affinity of the CD4 cytoplas-
mic domain for p561ck in Nef-expressing cells or may reflect
differences in the turnover of free CD4 and CD4-p56lck
complexes. Alanine substitution for residues L413 and L414
(L413A, L414A, Fig. 3C) also prevented the effect of Nef on
the steady-state level of CD4 protein and on CD4-p561ck
association (compare lanes 1 and 3 in the lower and upper
panels, respectively). Remarkably, for both of these mutations
(M407A, I410A and L413A, L414A), the mutant CD4-p56lck
complexes were still sensitive to PMA (compare lanes 1, 2, and
4, upper panels).
In contrast, substitution of K411 and R412 with negatively
charged amino acids (K411D, R412E), which had no detect-
able effect on Nef-induced CD4 internalization (see Fig. 1B,
panels 4A and 4B), also had no detectable effect on the
disruption of CD4-p56lck association by the viral protein
(K41 1D, R412E, compare lanes 1 and 3, Fig. 3D, upper panel).
However, this mutation prevented CD4 internalization (data
not shown) and disruption of p561ck complexes by PMA (Fig.
3D, lanes 1 and 2). These results indicate that disruption of
CD4-p561ck association by Nef correlates tightly with CD4
down-modulation, suggesting that both processes are tightly
coupled.
DISCUSSION
We have studied amino acid sequence requirements within the
cytoplasmic tail of CD4 for down-modulation by HIV-1 Nef
and for association with p561ck protein-tyrosine kinase. Our
observations indicate that in T cells the CD4 down-modulation
by Nef is critically dependent on a membrane-proximal cluster
of hydrophobic amino aci-ds, including methionine 407 and/or
isoleucine 410 and a di-leucine motif (leucines 413 and 414).
In addition, the C-terminal segment of the CD4 cytoplasmic
tail also contributes to the effect of Nef.
How might Nef interaction with these residues trigger CD4
down-modulation on the cell surface? The di-leucine motif,
required for internalization and lysosomal targeting of CD4 is
thought to mediate CD4 interaction with clathrin-coated pits
and is required for Nef- and PMA-induced CD4 endocytosis
(12, 22, 23, 26). Similar di-leucine motifs present in cytoplasmic
tails of the y and 8 chains of the CD3 complex are involved in
endocytosis and degradation of these molecules (31). In the
assembled multisubunit CD3 complexes at the cell surface, the
di-leucine motifs of the 'y and 8 chains are inaccessible for
interaction with the endocytotic machinery allowing stable
residence of the CD3 complex at the plasma membrane; they
become activated (unmasked) by phosphorylation of adjacent
serine residues, an event initiated by stimuli that mimic
antigenic stimulation and trigger endocytosis of the CD3
complex (31, 32).
The mechanism that occludes leucines 413 and 414 in the
CD4 cytoplasmic tail is not clear. Previous studies indicated
that p56lck binding to CD4 prevents its association with coated
pits and inhibits constitutive CD4 endocytosis via this route
(25, 26). However, preventing p56lck association with CD4 by
mutations in either of the two proteins, or expression of
wild-type CD4 in nonlymphoid cells, which do not contain
p561ck, does not result in acceleration of CD4 endocytosis
comparable to that observed in Nef-expressing cells (12, 25).
Thus, even in the absence of association with p56lck, leucines
413 and 414 are apparently rendered inaccessible by a partic-
ular conformation of the tail or are occluded by an interaction
with a protein other than p56lck.
PMA-dependent CD4 internalization requires phosphory-
lation of serines 408 and/or 415 (22, 24), which is thought to
promote the interaction of the di-leucine motif with clathrin-
coated pits. The effect of PMA is not affected by alanine
substitutions at methionine 407 or isoleucine 410 (data not
shown). In contrast, CD4 down-modulation by Nef does not
involve serine phosphorylation (7, 12) but requires methionine
407 and/or isoleucine 410. We suggest that these residues may
be required for an unmasking of the di-leucine motif induced
by Nef, by a mechanism independent of serine phosphoryla-
tion.
Our results indicate that, in addition to the double cysteine
motif, the membrane-proximal region in the cytoplasmic tail
that is involved in CD4 endocytosis is also essential for
efficient formation or stabilization of CD4-p561ck association.
The CD4-p56lck complex is thought to involve direct interac-
tion between the two proteins, mediated by cysteine motifs in
the N-terminal unique domain in p56'ck and the CD4 cyto-
plasmic tail (20,21). Thus the membrane-proximal segment in
the CD4 cytoplasmic tail may form additional contacts with
the p56lck unique domain. Our observations explain the pre-
viously noted relatively inefficient association of p561ck with
the cytoplasmic tail of CD8 (21, 33). CD8 binds p56lck via a
cysteine motif analogous to that found in CD4 (20, 21) but
lacks the membrane-proximal endocytosis motif and is not
internalized, or only marginally, in response to Nef (34) or
PMA (35, 36).
Our data do not, however, rule out the possibility that a third
component may be required for formation or stabilization of
CD4-p56lck complexes. Indeed, the relatively tight correlation
between the Nef-induced CD4 down-modulation and forma-
tion of CD4-p56lck observed with mutant CD4 proteins sug-
gests a model where an additional factor(s) could interact with
the membrane-proximal region in CD4 cytoplasmic tail mask-
ing the endocytotic motif and stabilizing CD4-p56lck associa-
tion. Possible candidates for such factors are suggested by a
recent observation that CD4 also associates with phosphati-
dylinositol (PI) 3-kinase and PI 4-kinase in T cells (37).
Although the functional significance of PI-3 and PI-4 kinase
association with CD4 has not been demonstrated, a role in
352 Cell Biology: Salghetti et at
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endocytosis is implied by a recent observation that PI-3 kinase
binding site is required for endocytosis of platelet-derived
growth factor receptor and by the involvement of both kinases
in protein sorting to lysosome-like vacuolar compartment in
Saccharomyces cerevisiae (38, 39).
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